Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 41% ± 19% | |
lung | 19 studies | 47% ± 15% | |
peripheral blood | 19 studies | 43% ± 18% | |
eye | 11 studies | 40% ± 16% | |
intestine | 10 studies | 39% ± 17% | |
kidney | 9 studies | 36% ± 8% | |
liver | 6 studies | 49% ± 17% | |
heart | 5 studies | 37% ± 13% | |
lymph node | 5 studies | 44% ± 11% | |
breast | 5 studies | 44% ± 15% | |
pancreas | 4 studies | 52% ± 22% | |
bone marrow | 4 studies | 45% ± 19% | |
uterus | 4 studies | 64% ± 17% | |
prostate | 4 studies | 41% ± 12% | |
adipose | 4 studies | 45% ± 10% | |
placenta | 3 studies | 56% ± 12% | |
esophagus | 3 studies | 40% ± 20% | |
skin | 3 studies | 32% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 81634.89 | 1445 / 1445 | 100% | 286.12 | 183 / 183 |
intestine | 100% | 104271.04 | 966 / 966 | 100% | 166.30 | 526 / 527 |
prostate | 100% | 100857.93 | 245 / 245 | 100% | 172.65 | 501 / 502 |
skin | 100% | 76035.21 | 1809 / 1809 | 100% | 152.94 | 471 / 472 |
uterus | 100% | 127828.56 | 170 / 170 | 100% | 152.89 | 458 / 459 |
stomach | 100% | 87398.07 | 359 / 359 | 100% | 189.39 | 285 / 286 |
pancreas | 100% | 69527.48 | 328 / 328 | 99% | 143.53 | 177 / 178 |
bladder | 100% | 84295.14 | 21 / 21 | 99% | 124.69 | 501 / 504 |
breast | 100% | 93482.99 | 459 / 459 | 99% | 199.91 | 1111 / 1118 |
thymus | 100% | 116378.48 | 652 / 653 | 100% | 149.59 | 602 / 605 |
ovary | 100% | 111441.24 | 180 / 180 | 99% | 178.81 | 427 / 430 |
lung | 100% | 91704.86 | 578 / 578 | 98% | 158.28 | 1137 / 1155 |
adrenal gland | 100% | 77355.82 | 258 / 258 | 98% | 104.47 | 225 / 230 |
kidney | 100% | 66117.63 | 89 / 89 | 98% | 130.72 | 880 / 901 |
liver | 100% | 48919.67 | 225 / 226 | 87% | 67.57 | 354 / 406 |
brain | 87% | 33844.95 | 2306 / 2642 | 99% | 170.81 | 699 / 705 |
adipose | 100% | 77532.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 127.44 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 135.67 | 29 / 29 |
muscle | 100% | 72067.49 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 120692.40 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 130.69 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 63.05 | 1 / 1 |
blood vessel | 100% | 68843.68 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 46253.92 | 843 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 45669.06 | 883 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0015030 | Cellular component | Cajal body |
GO_0016607 | Cellular component | nuclear speck |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071007 | Cellular component | U2-type catalytic step 2 spliceosome |
GO_0071005 | Cellular component | U2-type precatalytic spliceosome |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0070742 | Molecular function | C2H2 zinc finger domain binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | SRRM2 |
Protein name | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) Serine/arginine repetitive matrix 2 SRRM2 protein |
Synonyms | SRM300 KIAA0324 SRL300 HSPC075 |
Description | FUNCTION: Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). . |
Accessions | I3L4U6 I3L4D8 Q05BI2 ENST00000575870.6 I3L0N7 Q9UQ35 ENST00000576924.6 [Q9UQ35-1] ENST00000301740.13 [Q9UQ35-1] ENST00000572883.2 A0A994J493 I3L3Q8 A0A087X1W1 ENST00000574340.1 ENST00000576924.6 ENST00000575009.5 Q05CV9 A0AUK8 ENST00000571378.5 I3L182 ENST00000573692.1 I3L1I8 ENST00000570971.2 |